| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
53,543,000 |
| Market
Cap: |
12.03(B) |
| Last
Volume: |
1,301,402 |
Avg
Vol: |
474,564 |
| 52
Week Range: |
$164.52 - $273.43 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 8.5 |
| Insider 3/6 Months : 9.1 |
|
| Guru Rank Number : 456 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
1,322 |
7,942 |
11,192 |
| Total Buy Value |
$0 |
$248,298 |
$1,447,725 |
$2,162,353 |
| Total People Bought |
0 |
1 |
3 |
3 |
| Total Buy Transactions |
0 |
1 |
3 |
5 |
| Total Shares Sold |
17,698 |
31,794 |
48,856 |
91,693 |
| Total Sell Value |
$4,464,485 |
$7,692,626 |
$10,998,196 |
$21,364,499 |
| Total People Sold |
5 |
5 |
5 |
8 |
| Total Sell Transactions |
6 |
10 |
14 |
26 |
| End Date |
2024-02-16 |
2023-11-15 |
2023-05-17 |
2022-05-17 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wallman Richard F |
Director |
• • – |
2020-02-14 |
4 |
S |
$174.29 |
$615,258 |
D/D |
(3,530) |
29,367 |
|
-1% |
|
| Wallman Richard F |
Director |
• • – |
2020-02-14 |
4 |
OE |
$52.29 |
$184,584 |
D/D |
3,530 |
32,897 |
|
- |
|
| Wallman Richard F |
Director |
• • – |
2020-02-13 |
4 |
S |
$172.02 |
$1,233,391 |
D/D |
(7,170) |
29,367 |
|
0% |
|
| Wallman Richard F |
Director |
• • – |
2020-02-13 |
4 |
OE |
$43.39 |
$395,572 |
D/D |
7,170 |
36,537 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-02-13 |
4 |
S |
$171.88 |
$2,578,440 |
D/D |
(15,000) |
298,064 |
|
0% |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-02-13 |
4 |
S |
$172.11 |
$1,187,699 |
D/D |
(6,901) |
18,931 |
|
0% |
|
| Bertolini Robert J |
Director |
• • – |
2020-02-13 |
4 |
S |
$170.41 |
$1,221,819 |
D/D |
(7,170) |
27,875 |
|
0% |
|
| Bertolini Robert J |
Director |
• • – |
2020-02-13 |
4 |
OE |
$43.39 |
$395,572 |
D/D |
7,170 |
35,045 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2020-02-13 |
4 |
S |
$172.05 |
$154,845 |
D/D |
(900) |
23,714 |
|
0% |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-02-13 |
4 |
S |
$170.29 |
$766,319 |
D/D |
(4,500) |
21,978 |
|
0% |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2020-02-07 |
4 |
D |
$159.07 |
$611,783 |
D/D |
(3,846) |
24,614 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2020-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,745 |
28,460 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-02-07 |
4 |
D |
$159.07 |
$800,281 |
D/D |
(5,031) |
26,478 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
13,431 |
31,509 |
|
- |
|
| Johst David P |
Corporate Executive VP |
• • – |
2020-02-07 |
4 |
D |
$159.07 |
$1,525,799 |
D/D |
(9,592) |
226,990 |
|
- |
|
| Johst David P |
Corporate Executive VP |
• • – |
2020-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
23,728 |
236,582 |
|
- |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2020-02-07 |
4 |
D |
$159.07 |
$611,783 |
D/D |
(3,846) |
20,312 |
|
- |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2020-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,745 |
24,158 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-02-07 |
4 |
D |
$159.07 |
$5,062,244 |
D/D |
(31,824) |
313,064 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
73,873 |
344,888 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-02-07 |
4 |
D |
$159.07 |
$611,465 |
D/D |
(3,844) |
25,832 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,745 |
29,676 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-01-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,500 |
271,015 |
|
- |
|
| Johst David P |
Corporate Executive VP |
• • – |
2019-12-09 |
4 |
AS |
$143.80 |
$3,556,341 |
D/D |
(24,660) |
212,854 |
|
- |
|
| Johst David P |
Corporate Executive VP |
• • – |
2019-12-09 |
4 |
OE |
$76.67 |
$1,890,682 |
D/D |
24,660 |
237,514 |
|
- |
|
2027 Records found
|
|
Page 20 of 82 |
|
|
7.81 (3.36%) 
